© 2023 Sozo Wellness Centers of America. All Rights Reserved.
For referring providers, Sozo Wellness Centers of America is your collaborative partner. Sozo Wellness Centers of America is your collaborative partner for your patients with Treatment Resistant Depression. We are a REMS certified spravato treatment center. At Sozo, we understand that when you refer one of your patients to us for SPRAVATO®, that patient remains your patient. Consider Sozo as an extension of your practice. Our trained caregivers, like you, have your patient’s wellness as our highest priority. From initial intake to navigating insurance, Sozo believes in supporting your patients journey with us so that they never feel alone. At Sozo we practice the Art of Healing.
SPRAVATO® is derived from ketamine, a drug that has been used in hospitals as an anesthetic since the 1970s. This esketamine nasal spray helps in alleviating symptoms of depression is a more recent discovery. SPRAVATO® esketamine treatment for depression is unique in that it is self-administered in our office under the supervision of a trained healthcare professional. After administering SPRAVATO® you will remain in one of our comfortable Wellness Suites for two hours as mandated by the FDA. Our trained Sozo caregivers will ensure you are safe and help alleviate any adverse side effects.
Our healthcare professionals are experts at evaluating your specific needs and the medications you have tried in the past. During your initial evaluation, we will review your medical history and together map out a treatment plan that is best for you that may include SPRAVATO®.
SPRAVATO® treatments can last over several months. Together we will work to create a SPRAVATO® treatment plan. Typically, SPRAVATO® esketamine treatment is broken into two phases; the Induction Phase, or beginning; and the Maintenance Phase, or ongoing treatments. The Induction Phase lasts one month and SPRAVATO® esketamine nasal spray is administered twice a week in our office. The Maintenance Phase may last as long as you and your healthcare professional deem it helpful.
Every insurance company is different. Our goal is to take the burden of dealing with your insurance company off of your shoulders and onto ours. After you provide us with your insurance information, we obtain preauthorization, manage your deductibles and co-pays and follow up with your insurance company to obtain payment. At Sozo, we want you to focus on your most important task: getting better and overcoming therapy resistant depression.
It is important that you take all the necessary steps to maximize the best possible outcome of your SPRAVATO® treatments. Here are a few steps to consider before each treatment:
SPRAVATO® treatments can last over several months. Together we will work to create a SPRAVATO® treatment plan. Typically, SPRAVATO® is broken into two phases; the Induction Phase, or beginning; and the Maintenance Phase, or ongoing treatments. The Induction Phase lasts one month and SPRAVATO® is administered twice a week in our office. The Maintenance Phase may last as long as you and your healthcare professional deem it helpful.
Spravato REMS treatment has been FDA-approved since 2019 and evaluated in both short- and long-term trials for safety and efficacy. Because Spravato® is administered in our office, patients will be monitored closely for any adverse side effects.
Before starting Spravato® esketamine treatment, we will discuss all potential side effects and interactions, and make sure Spravato® is right for you.